Test & measurement
Feature sponsored by
Measurement technology for drugs
Why process monitoring is essential
Ivers-Lee has taken advantage of Kistler’s integrated force-displacement monitoring in its assembly lines for drug-device combination products. Sensors and process monitoring systems operate in the final stage of the assembly process for auto-injectors and pen systems, ensuring that these self-medication products meet the highest quality standards.
whose incidence is on the rise amid growing affluence - and not infrequently the result of a
T 14
hanks to advances in the medtech and pharmaceutical industries, patients can now manage the treatment of many conditions themselves. One example is diabetes, a disease
combination of an unbalanced diet and too little exercise. Self-management of this and many other conditions is more comfortable for the patient, and saves trips to the doctor; however, this requires totally reliable, user- friendly devices of the highest quality. Nevertheless, many hurdles need to be
overcome before a suitable product is approved for commercial marketing. Above all, clinical studies must be carried out to verify the efficacy of the drug; such studies are very costly and extremely time consuming. To streamline the obligatory processes and reduce time-to-market for their products, many pharmaceutical manufacturers invite Ivers-Lee to come on board. This Swiss company can look back on a long tradition of leadership in its field. It has a workforce of 100 at its headquarters in Burgdorf near Bern and another 10 employees at its site in Lörrach, Germany.
Integrated force meaSurement technoLogy enSureS 100 per cent teStIng Dr. Peter Schüpbach, CEO of Ivers-Lee, says: “We help our customers in the pharmaceutical sector to develop a market- ready product. To achieve this, we draw on our lengthy experience of providing solutions for production, packing and labeling.” Ivers- Lee’s operations focus mainly on blister packaging and stickpacks as well as assembly of combination products. Preparation of these combined drug-device kits involves assembling, packing and labelling a suitable device for administering medication together with a drug container (syringe, glass vial, etc.). Patients can then use these kits to manage their own treatment. “Our assembly depar tment is par ticularly successful in connection with clinical studies. As a development par tner for pharmaceutical companies, we offer an efficient platform that enables them to bring their combination products to market
The auto-injector from Ypsomed is one of two platforms that are combined with drugs and reliably finished at Ivers-Lee – thanks to the integrated process monitoring solution from Kistler (Source: Ypsomed).
August 2022 Instrumentation Monthly
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102
